摘要
背景:据估计,从确诊阿尔茨海默病(AD)到患者死亡的平均时间为 5-9 年。因此,无论是疾病的初始阶段还是临床前状态,都可以纳入疾病诊断的关键期。因此,最近在生物标志物研究方面取得了巨大进展,以识别具有正常认知功能和轻度认知障碍的老年人痴呆症的危险因素。 方法:电化学生物传感器是一种优秀的分析工具,用于检测 AD 生物标志物,因为它们易于使用、便携且可以进行实时分析。 结果:这篇综述介绍了目前用于确定 AD 生物标志物的分析技术的优缺点; AD 最重要的临床生物标志物及其在疾病中的作用。首次总结了电化学生物传感器开发中最近使用的所有生物识别分子,即受体蛋白、抗体、适体和核酸。还回顾了用于 AD 生物标志物检测的新型电化学生物传感器,作为即时诊断的理想分析平台。 结论:本文重点介绍了生物传感器化学表面修饰的各种策略,以固定生物识别分子,从而在合成和临床样本中实现特异性、定量的 AD 生物标志物检测。此外,这是第一次介绍基于电化学技术同时检测多种生物标志物和其他重要 AD 相关生物物种的创新单平台系统。讨论了这些平台在疾病诊断中的重要性。
关键词: 阿尔茨海默病、生物标志物检测、早期诊断、生物传感器、表面改性、多重检测。
Current Medicinal Chemistry
Title:Recent Advancements in Electrochemical Biosensors for Alzheimer’s Disease Biomarkers Detection
Volume: 28 Issue: 20
关键词: 阿尔茨海默病、生物标志物检测、早期诊断、生物传感器、表面改性、多重检测。
摘要:
Background: It is estimated that the average time between the diagnosis of Alzheimer’s disease (AD) and the patient’s death is 5-9 years. Therefore, both the initial phase of the disease and the preclinical state can be included in the critical period in disease diagnosis. Accordingly, huge progress has recently been observed in biomarker research to identify risk factors for dementia in older people with normal cognitive functions and mild cognitive impairments.
Methods: Electrochemical biosensors are excellent analytical tools that are used in the detection of AD biomarkers as they are easy to use, portable, and can do analysis in real time.
Results: This review presents the analytical techniques currently used to determine AD biomarkers in terms of their advantages and disadvantages; the most important clinical biomarkers of AD and their role in the disease. All recently used biorecognition molecules in electrochemical biosensor development, i.e., receptor protein, antibodies, aptamers and nucleic acids, are summarized for the first time. Novel electrochemical biosensors for AD biomarker detection, as ideal analytical platforms for point-of-care diagnostics, are also reviewed.
Conclusion: The article focuses on various strategies of biosensor chemical surface modifications to immobilize biorecognition molecules, enabling specific, quantitative AD biomarker detection in synthetic and clinical samples. In addition, this is the first review that presents innovative single-platform systems for simultaneous detection of multiple biomarkers and other important AD-associated biological species based on electrochemical techniques. The importance of these platforms in disease diagnosis is discussed.
Export Options
About this article
Cite this article as:
Recent Advancements in Electrochemical Biosensors for Alzheimer’s Disease Biomarkers Detection, Current Medicinal Chemistry 2021; 28 (20) . https://dx.doi.org/10.2174/0929867327666201111141341
DOI https://dx.doi.org/10.2174/0929867327666201111141341 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Neuronal Nicotinic Receptors: a Path to New Therapies
Current Drug Targets - CNS & Neurological Disorders Metformin: A Growing Journey from Glycemic Control to the Treatment of Alzheimer’s Disease and Depression
Current Medicinal Chemistry Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets The Valsalva Maneuver and Alzheimers Disease: Is there a link?
Current Alzheimer Research Applying Melanopic Lux to Measure Biological Light Effects on Melatonin Suppression and Subjective Sleepiness
Current Alzheimer Research Editorial from Guest Editor [Hot topic: Community-Acquired Pneumonia – Evolving Changes in Our Understanding and How This Impacts on Management (Guest Editor: Grant Waterer)]
Current Respiratory Medicine Reviews The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases
Current Pharmaceutical Design Proteomic Approaches Contributing to the Understanding of Neurodegenerative Diseases: Focus on Alzheimers Disease
Current Proteomics Functional Interactions of Tau and their Relevance for Alzheimers Disease
Current Alzheimer Research Chemistry and Pharmacological Properties of Some Natural and Synthetic Antioxidants for Heavy Metal Toxicity
Current Medicinal Chemistry Traumatic Brain Injury as a Risk Factor for Schizophrenia
Current Psychiatry Reviews Synaptic Dysfunction in Synucleinopathies
CNS & Neurological Disorders - Drug Targets Synthesis and Biological Activity of New 2,3-dihydro-1H-cyclopenta[b]- quinoline Derivatives as Acetylcholinesterase Inhibitors
Letters in Drug Design & Discovery Neurotoxicity of Insecticides
Current Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Ultrasound Diagnostic Method in Vascular Dementia: Current Concepts
Current Medical Imaging Metformin Eased Cognitive Impairment Induced by Chronic L-methionine Administration: Potential Role of Oxidative Stress
Current Neuropharmacology Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium]
CNS & Neurological Disorders - Drug Targets Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F)
Current Alzheimer Research Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer's Disease - A Translational Perspective
CNS & Neurological Disorders - Drug Targets